...KRAS, BRAF mutation status, tumor site, T/N stage, gender, or age.,Patients with stage III CC undergoing adjuvant chemot...
...KRAS is regulated. The promoter of KRAS contains a GA-element composed of runs of guanines that fold into a G4 structure...
Kras mutation is a common phenomenon in many human neoplasms. We aimed to assess the Kras mutational status along the hi...
...KRAS and BRAF gene mutations and none of them showed gene mutations.,We could not find any relation between OSCC and KRA...
...Kras;Trp53;Pdx-1-Cre) mouse models of pancreatic cancer were used to evaluate the in vivo efficacy of AR-42 in suppressi...
...KRAS oncogene. Activation of WNT signaling is also commonly observed in PDAC. To ascertain the impact of postnatal activ...
...KRAS and BRAF mutations are rare events in this type of cancer. However, no data are available on NRAS status in SCAC. I...
...KRAS). One patient who had a nodule classified as NIFTP had metastatic carcinoma identified in a lymph node. Another who...
...Kras model, but not parental Kras mice in which STAT3 was not hyperactivated. Gene expression profiling of muscle tissue...
...Kras. Pharmacological inhibition of TGFβ-VAV1 signalling decreased the squamous/EMT-like cancer cells, promoted nuclear ...
联系地址
山东省济南市章丘区文博路2号
齐鲁师范学院 genelibs生信实验室
山东省济南市高新区舜华路750号
大学科技园北区F座4单元2楼
电话： 0531-88819269
版权所有 © 2025.Genelibs 济南弘晖生物技术有限公司 鲁ICP备20007159号-2
